Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 Dec 2023
Historique:
received: 12 09 2023
accepted: 17 11 2023
medline: 4 12 2023
pubmed: 3 12 2023
entrez: 2 12 2023
Statut: epublish

Résumé

Off-target interactions between antisense oligonucleotides (ASOs) with state-of-the-art modifications and biological components still pose clinical safety liabilities. To mitigate a broad spectrum of off-target interactions and enhance the safety profile of ASO drugs, we here devise a nanoarchitecture named BRace On a THERapeutic aSo (BROTHERS or BRO), which is composed of a standard gapmer ASO paired with a partially complementary peptide nucleic acid (PNA) strand. We show that these non-canonical ASO/PNA hybrids have reduced non-specific protein-binding capacity. The optimization of the structural and thermodynamic characteristics of this duplex system enables the operation of an in vivo toehold-mediated strand displacement (TMSD) reaction, effectively reducing hybridization with RNA off-targets. The optimized BROs dramatically mitigate hepatotoxicity while maintaining the on-target knockdown activity of their parent ASOs in vivo. This technique not only introduces a BRO class of drugs that could have a transformative impact on the extrahepatic delivery of ASOs, but can also help uncover the toxicity mechanism of ASOs.

Identifiants

pubmed: 38042877
doi: 10.1038/s41467-023-43714-0
pii: 10.1038/s41467-023-43714-0
pmc: PMC10693639
doi:

Substances chimiques

Oligonucleotides, Antisense 0
RNA 63231-63-0
Peptide Nucleic Acids 0
Phosphorothioate Oligonucleotides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7972

Subventions

Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 22H02783
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 20H05874
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP22KJ2503
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP22J20853
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 22H02783
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 22H02783
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 20H05874

Informations de copyright

© 2023. The Author(s).

Références

Sci Rep. 2016 Jul 27;6:30377
pubmed: 27461380
Nucleic Acids Res. 2018 Mar 16;46(5):2204-2217
pubmed: 29390093
Nucleic Acids Res. 2020 Feb 28;48(4):1691-1700
pubmed: 31980820
Mol Ther. 2017 Sep 6;25(9):2075-2092
pubmed: 28663102
Nat Rev Gastroenterol Hepatol. 2018 Dec;15(12):738-752
pubmed: 30250076
J Mol Cell Biol. 2017 Oct 1;9(5):395-408
pubmed: 28369514
Nucleic Acids Res. 2016 Mar 18;44(5):2093-109
pubmed: 26553810
J Am Chem Soc. 2011 Feb 23;133(7):2177-82
pubmed: 21268641
Wiley Interdiscip Rev RNA. 2020 Sep;11(5):e1594
pubmed: 32233021
Nucleic Acid Ther. 2013 Oct;23(5):302-10
pubmed: 23952551
J Med Chem. 2010 Feb 25;53(4):1636-50
pubmed: 20108935
EMBO J. 2002 Jul 1;21(13):3476-85
pubmed: 12093748
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253
pubmed: 32356888
Nucleic Acids Res. 2010 Nov;38(20):7100-11
pubmed: 20615897
EMBO Mol Med. 2021 Apr 9;13(4):e13243
pubmed: 33821570
Mol Ther Nucleic Acids. 2014 Feb 18;3:e149
pubmed: 24549300
Nature. 1993 Oct 7;365(6446):566-8
pubmed: 7692304
Mol Ther Nucleic Acids. 2020 Mar 6;19:706-717
pubmed: 31951854
Cell Signal. 2012 May;24(5):981-90
pubmed: 22286106
Cell. 2018 Jul 12;174(2):300-311.e11
pubmed: 30007416
Science. 1991 Dec 6;254(5037):1497-500
pubmed: 1962210
Nat Biotechnol. 2019 Jun;37(6):640-650
pubmed: 31036929
Biochem Pharmacol. 1994 Sep 15;48(6):1310-3
pubmed: 7945427
Nucleic Acids Res. 2021 Sep 20;49(16):9026-9041
pubmed: 34417625
J Am Chem Soc. 2020 Sep 2;142(35):14754-14771
pubmed: 32786803
Chem Rev. 2016 Nov 23;116(22):13752-13990
pubmed: 27754649
Pharmaceutics. 2021 May 31;13(6):
pubmed: 34072682
Nat Commun. 2014 Nov 10;5:5324
pubmed: 25382214
Pharmaceutics. 2022 Nov 29;14(12):
pubmed: 36559141
Nucleic Acids Res. 2015 Oct 15;43(18):8638-50
pubmed: 26338776
Nucleic Acids Res. 2022 Jul 22;50(13):7224-7234
pubmed: 35801870
Front Cell Dev Biol. 2020 May 21;8:365
pubmed: 32671059
Toxicol Pathol. 2015 Jan;43(1):78-89
pubmed: 25385330
Nucleic Acid Ther. 2021 Dec;31(6):404-416
pubmed: 34468210
Nucleic Acids Res. 2018 Jun 20;46(11):5366-5380
pubmed: 29790953
Future Med Chem. 2011 Mar;3(3):339-65
pubmed: 21446846
Nucleic Acids Res. 2017 Oct 13;45(18):10649-10671
pubmed: 28977508
RNA. 2007 Jul;13(7):1043-51
pubmed: 17526645
J Med Chem. 2016 Nov 10;59(21):9645-9667
pubmed: 27434100
J Biol Chem. 2021 Jan-Jun;296:100416
pubmed: 33600796
Nucleic Acid Ther. 2021 Apr;31(2):114-125
pubmed: 33470890
Nucleic Acids Res. 2021 Jun 21;49(11):6114-6127
pubmed: 34125895
Mol Ther Nucleic Acids. 2012 Sep 18;1:e47
pubmed: 23344239
Nucleic Acids Res. 2015 Oct 30;43(19):e128
pubmed: 26101258
Nucleic Acid Ther. 2014 Aug;24(4):283-90
pubmed: 24758560
Mol Diagn Ther. 2022 Jan;26(1):117-127
pubmed: 34994962
Toxicol Sci. 2007 Jun;97(2):539-47
pubmed: 17361016
Genes Cells. 2019 Dec;24(12):827-835
pubmed: 31637814
Mitochondrion. 2021 Jul;59:83-95
pubmed: 33812964
Mol Cell. 2019 Feb 7;73(3):490-504.e6
pubmed: 30581145
Bioinformatics. 2019 Nov 15;:
pubmed: 31730197
Nucleic Acid Ther. 2022 Feb;32(1):40-50
pubmed: 34698585
Bioorg Med Chem. 2016 Jan 1;24(1):26-32
pubmed: 26678173
Nat Commun. 2018 Jan 29;9(1):420
pubmed: 29379020
Nucleic Acids Res. 2015 Mar 11;43(5):2927-45
pubmed: 25712094
Nucleic Acids Res. 2016 Feb 29;44(4):1937-43
pubmed: 26717983
J Med Chem. 2009 Jan 8;52(1):10-3
pubmed: 19086780
J Am Chem Soc. 2020 Jul 1;142(26):11451-11463
pubmed: 32496760
Nucleic Acids Res. 2021 Feb 26;49(4):1828-1839
pubmed: 33544849
Nucleic Acids Res. 2014 Apr;42(8):4882-91
pubmed: 24550163
Cold Spring Harb Perspect Biol. 2020 Aug 3;12(8):
pubmed: 31712266
Mol Ther Nucleic Acids. 2018 Mar 2;10:45-54
pubmed: 29499955
Nat Rev Drug Discov. 2020 Oct;19(10):673-694
pubmed: 32782413
Am J Physiol Cell Physiol. 2007 Apr;292(4):C1388-97
pubmed: 17135295
Antisense Nucleic Acid Drug Dev. 2002 Apr;12(2):65-70
pubmed: 12074366
Nat Biotechnol. 2012 Oct;30(10):920-3
pubmed: 23051805
PLoS One. 2020 Jun 12;15(6):e0232603
pubmed: 32530964
Nucleic Acids Res. 2016 Jun 20;44(11):5010-21
pubmed: 27131787
Nucleic Acid Ther. 2020 Aug;30(4):215-228
pubmed: 32125928
Acta Crystallogr D Biol Crystallogr. 2015 Jul;71(Pt 7):1423-32
pubmed: 26143914

Auteurs

Chisato Terada (C)

Department of Chemistry of Biofunctional Molecules, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
JSPS Research Fellow (DC1), Japan Society for the Promotion of Science, Tokyo, Japan.

Kaho Oh (K)

Department of Chemistry of Biofunctional Molecules, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Ryutaro Tsubaki (R)

Department of Chemistry of Biofunctional Molecules, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Bun Chan (B)

Graduate School of Engineering, Nagasaki University, Nagasaki, Japan.

Nozomi Aibara (N)

Department of Pharmacy Practice, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Kaname Ohyama (K)

Department of Molecular Pathochemistry, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Masa-Aki Shibata (MA)

Department of Anatomy and Cell Biology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Takehiko Wada (T)

Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, Sendai, Miyagi, Japan.

Mariko Harada-Shiba (M)

Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
Cardiovascular Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

Asako Yamayoshi (A)

Department of Chemistry of Biofunctional Molecules, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Tsuyoshi Yamamoto (T)

Department of Chemistry of Biofunctional Molecules, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. tsuyoshi.yamamoto@nagasaki-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH